Summary of Henry Schein FY Conference Call (March 10, 2026) Company Overview - **Company**: Henry Schein (NasdaqGS:HSIC) - **Industry**: Dental distribution and healthcare products Key Highlights from Q4 2025 - **Dental Business Growth**: Notable improvement in dental distribution growth in both the U.S. and international markets, indicating market share gains [4][5] - **Equipment Sales**: U.S. dental equipment sales exceeded 10% growth in Q4, significantly outpacing market trends, reflecting customer confidence in practice investments [5][6] - **Market Share**: Successful promotional programs contributed to growth, with a focus on new customer acquisition [5][14] Financial Guidance for 2026 - **Earnings Per Share (EPS)**: Guidance set at $5.23-$5.37, representing a 5%-8% growth [8] - **Cost Management**: Anticipated costs related to value creation initiatives in the first half of the year, with earnings growth expected to be more pronounced in the second half [9] Segment Performance - **Dental Specialty**: Strong growth in dental implants, particularly in Europe, with steady growth in the U.S. driven by a new value implant [7][41] - **Technology**: Henry Schein One holds approximately 50% market share in dental practice management systems, with new product launches aimed at improving operational efficiency for customers [7][8] - **Merchandise Growth**: Achieved 3%-4% growth in merchandise, attributed to promotional activities and recruitment of experienced sales representatives [36] Innovation and Market Trends - **Digital Transition**: Many dental practices have yet to fully embrace digital technologies, indicating a long runway for growth in digital equipment sales [22][29] - **Intraoral Scanners**: Price reductions in scanners are attracting more practices, facilitating further sales of digital equipment [29][31] Leadership Changes and Strategic Direction - **New CEO**: Fred Lowery appointed as CEO, succeeding Stanley Bergman, with a focus on fresh perspectives and strategic execution [53][56] - **KKR Investment**: KKR now holds a 19.9% stake in the company, providing new board members and a collaborative culture that supports value creation initiatives [57][60] Capital Deployment Strategy - **Share Buybacks**: $850 million in stock repurchases executed, indicating belief in the stock's undervaluation [66] - **M&A Activity**: Slower pace of acquisitions noted, with a focus on share repurchases as a priority for capital deployment [68] Market Outlook - **Positive Market Sentiment**: Signs of optimism in the dental market, with peers showing recovery from previous challenges [71] - **Customer Confidence**: Equipment sales results suggest a confident customer base willing to invest in their practices, positioning Henry Schein favorably for future growth [72]